HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting.

Abstract
A systematic review and meta-analysis was performed to evaluate the effects of carvedilol versus metoprolol on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting in randomized controlled trials. Ovid MEDLINE, PubMed, CENTRAL, and Excepta Medica (EMBASE) were searched up to March 2013 for suitable randomized controlled trials. Data were pooled using random-effects model for pairwise analyses. A total of 4 trials with 601 patients were included in this analysis. Pairwise analyses showed that compared with metoprolol, carvedilol significantly reduced the incidence of postoperative atrial fibrillation (odds ratio 0.50, 95% confidence interval 0.32 to 0.80). In conclusion, compared with metoprolol, carvedilol significantly reduces the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
AuthorsJames J DiNicolantonio, Craig J Beavers, Arthur R Menezes, Carl J Lavie, James H O'Keefe, Pascal Meier, András Vorobcsuk, Dániel Aradi, András Komócsi, Saurav Chatterjee, Fabrizio D'Ascenzo, Mauro Gasparini, Jasper Brugts, Giuseppe Biondi-Zoccai
JournalThe American journal of cardiology (Am J Cardiol) Vol. 113 Issue 3 Pg. 565-9 (Feb 01 2014) ISSN: 1879-1913 [Electronic] United States
PMID24332247 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Adrenergic alpha-1 Receptor Antagonists
  • Anti-Arrhythmia Agents
  • Carbazoles
  • Propanolamines
  • Carvedilol
  • Metoprolol
Topics
  • Adrenergic alpha-1 Receptor Antagonists (therapeutic use)
  • Anti-Arrhythmia Agents (therapeutic use)
  • Atrial Fibrillation (etiology, prevention & control)
  • Carbazoles (therapeutic use)
  • Carvedilol
  • Coronary Artery Bypass (adverse effects)
  • Coronary Artery Disease (surgery)
  • Humans
  • Metoprolol (therapeutic use)
  • Postoperative Period
  • Propanolamines (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: